Health insurance to expand coverage to Glivec

The costs that individuals will have to shoulder for treatment of Gastrointestinal Stromal Tumors (GISTs) will go down from March 1 thanks to the government’s plan to expand the national health insurance coverage for Glivec, the Ministry for Health, Welfare and Family Affairs said recently.

In March of last year, the Korea Food and Drug Administration approved the Novartis drug Glivec (imati...